Most Awaited Q3 Sale is back. Upto 30% discount on every report.
Apixaban API Market Size, Share, Industry, Forecast and outlook (2023-2030)
Published: 2023 August 04
SKU : PH3558
180 pages
Report Summary
Table of Contents
List of Tables & Figures
Buy this report
Single User
Multiple User
Enterprise User
Request new version
FAQ’s
Who are the Major key players in Apixaban API Market ?
Neuraxpharm / INKE, Amtec Health Care Pvt. Ltd, Basic Pharma Life Science Pvt Ltd, Tianyu Pharm, Element Chemilink Pvt Ltd, Teva, Mehta API Pvt Ltd, Jinan Jianfeng Chemical Co., Ltd, Hisun, CTX Life Sciences.
Which is the Largest Market Share in the Apixaban API Market ?
North America is the Largest Market Share in Apixaban API Market.
Which is the fastest growing region in the Apixaban API Market ?
Asia Pacific is the fastest-growing region in the Apixaban API Market.
What is Apixaban Medication used for?
It is an anticoagulant drug used to treat thromboembolic diseases sold under the trade name Eliquis. It acts by inhibiting coagulation which prevents the development of blood clots.
Related Reports
pharmaceuticalsPorphyria Treatment Market Size, Share, Industry, Forecast and outlook (2023-2030)
Published: 2023 January 19
Starting from
$4350
pharmaceuticalsAcute Otitis Media Treatment Market Size, Share, Industry, Forecast and outlook (2023-2030)
Published: 2023 September 21
Starting from
$4350
pharmaceuticalsSinusitis Treatment Market Size, Share, Industry, Forecast and outlook (2023-2030)
Published: 2023 September 25
Starting from
$4350
pharmaceuticalsCholesteatoma Treatment Market Size, Share, Industry, Forecast and outlook (2023-2030)
Published: 2023 January 19
Starting from
$4350
pharmaceuticalsMitochondrial Myopathies Treatment Market Size, Share, Industry, Forecast and outlook (2023-2030)
Published: 2023 October 27
Starting from
$4350
pharmaceuticalsAcute Intermittent Porphyria Market Size, Share, Industry, Forecast and outlook (2023-2030)
Published: 2022 October 06
Starting from
$4350